Targeted panel boosts accuracy of hereditary pancreatitis testing: Experts: Linda Hasadsri, M.D., Ph.D., and Huong T. Cabral, M.S., C.G.C.

Answers from the Lab

Content provided by Mayo Clinic Laboratories. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Mayo Clinic Laboratories or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

3M ago 10:24

MP3•Episode home

Linda Hasadsri, M.D., Ph.D., and Huong T. Cabral, M.S., C.G.C., explain how Mayo Clinic Laboratories' targeted test panel facilitates accurate diagnosis of hereditary pancreatitis, which heightens the risk for pancreatic cancer. Test results can guide cancer monitoring for patients and their families.

(00:33)
Dr. Hasadsri, can you tell the audience a little bit about yourself and your background?

(01:32)
And Ms. Cabral?

(02:03)
Can you please give the audience a brief overview of this assay?

(03:33)
Which patients should have this testing and when should it be performed?

(04:23)
What alternative test options are available and how do these compare to our hereditary pancreatitis test?

(08:48)
How are results used in patient care?

308 episodes

#Science #Fitness #Medicine #Mayo Clinic Podcast For Laboratory #Laboratory Medicine #Healthcare #Lab #Mayo Clinic #Clinical #Dlmp #Morice #Pritt